article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

US Legal Requirements for Quantum-Powered Medical Devices In the United States, some quantum-powered medical devices may be governed under the existing FDA regulatory framework. Foster Institutional Plasticity: Evolve institutions like the FDA and EMA to accommodate quantum technologies.

FDA 182
article thumbnail

Psychedelics Are Cheap. Psychedelic Treatment Is Not.

Bill of Health

The FDA approved S-ketamine to treat depression in 2019. Still, to me, the most promising route to access is probably through FDA approval (which means more clinical trials) and expanded insurance coverage. Yet, insurance coverage alone is an imperfect solution because millions of Americans have no health insurance.

FDA 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insurance Coverage for Psychedelic Therapy

Bill of Health

By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. This is typical—without a seal of approval from FDA, insurers are reluctant to pay for off-label treatments.

FDA 203
article thumbnail

Addressing Bias in Healthcare AI: A Guide for Developers and Clinicians

HIT Consultant

Food and Drug Administration (FDA) regulates AI-based medical devices under its software as a medical device (SaMD) category. The FDA also enforces post-market surveillance to monitor AI performance after its deployment.

FDA 105
article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

The main federal health privacy law, the Health Insurance Portability and Accountability Act of 1996 (HIPAA) applies only to “covered entities” like health insurers, claims- processing clearinghouses, and health care providers and their business associates, and only to a subset of protected health care information.

FDA 288
article thumbnail

‘Care Anywhere’ is the new normal, according to industry report

Healthcare It News

Before joining BCGDV, they practised as medical doctors or worked in industries such as health insurance, medtech or pharma”, the company spokesperson informed Healthcare IT News. The report series aims to present “what industry leaders must know in order to navigate the changing means and modes of health care delivery.

COVID-19 264
article thumbnail

‘Care Anywhere’ is the new normal, according to new industry report

Healthcare It News

Before joining BCGDV, they practised as medical doctors or worked in industries such as health insurance, medtech or pharma”, the company spokesperson informed Healthcare IT News. The report series aims to present “what industry leaders must know in order to navigate the changing means and modes of health care delivery.

COVID-19 246